Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients-Reference-Cited by-同舟云学术

Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients

Published:2020-06-09 Issue:5 Volume:4 Page:929-936
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Araki Norimasa¹^ORCID,Takahashi Hirokazu¹^ORCID,Takamori Ayako²,Kitajima Yoichiro¹³,Hyogo Hideyuki⁴,Sumida Yoshio⁵,Tanaka Saiyu⁶,Anzai Keizo¹,Aishima Shinichi⁷,Chayama Kazuaki⁸,Fujimoto Kazuma⁹,Eguchi Yuichiro³

Affiliation:

1. Department of Internal Medicine, Faculty of Medicine Saga University Saga Japan

2. Clinical Research Center Saga University Hospital Saga Japan

3. Liver Center Saga University Hospital Saga Japan

4. Department of Gastroenterology and Hepatology JA Hiroshima General Hospital Hatsukaichi Japan

5. Division of Hepatology and Pancreatology, Department of Internal Medicine Aichi Medical University Aichi Japan

6. Center for Digestive and Liver Disease Nara City Hospital Nara Japan

7. Department of Pathology & Microbiology, Faculty of Medicine Saga University Saga Japan

8. Department of Gastroenterology and Metabolism Graduate School of Biomedical and Health Sciences, Hiroshima University Hiroshima Japan

9. Faculty of Medicine International University of Health and Welfare Fukuoka Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12367

Reference41 articles.

1. Current and future pharmacological therapies for NAFLD/NASH

2. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease

3. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients

4. Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases

5. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis;Digestive Diseases and Sciences;2024-03-04

2. Pretransplant HOMA-β Is Predictive of Insulin Independence in 7 Patients With Chronic Pancreatitis Undergoing Islet Autotransplantation;Transplantation Direct;2022-09-16

3. Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis;Annals of Translational Medicine;2022-08

4. Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease;Nutrients;2021-09-09

5. Analysis of the formation of dysglycemia in the substantiation of early pathogenetic therapy of diabetes mellitus;Meditsinskiy sovet = Medical Council;2021-05-12